The Effect of SPecialty cAre on Recovery From Cardiac Arrest Trial (the SPARC Trial)
Launched by UNIVERSITY OF PITTSBURGH · May 23, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The SPARC Trial is a study that aims to find out if patients who have experienced a cardiac arrest outside of a hospital recover better when they are transferred to specialized cardiac centers for treatment. The trial will focus on adults who have been successfully resuscitated and are in the emergency department. Researchers want to see if receiving care at a specialized hospital improves the patients' recovery after 90 days compared to those who receive care at a nearby hospital.
To be eligible for this trial, participants must be at least 18 years old, have had a cardiac arrest outside of the hospital, and have been brought back to life with a pulse in the emergency department. Participants will receive standard medical care, and some will be transferred to a regional cardiac arrest center while others will stay at the nearest appropriate hospital. After three months, the researchers will check in with the participants to assess how well they are recovering. This study is not yet recruiting participants, but it aims to provide valuable insights into the best care for heart arrest survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Out-of-hospital cardiac arrest
- • Resuscitated from cardiac arrest with palpable pulse in the emergency department
- • Treated at one of participating hospital emergency departments
- • Age ≥18 years
- Exclusion Criteria:
- • Known prior advanced directives or decision to limit critical care
- • Known pre-arrest dependent functional status (e.g., living in a skilled nursing facility, hospice or bedbound)
- • Arrest in the emergency department \>4 hours after arrival
- • Traumatic etiology of arrest
- • Known to have opted-out from the SPARC trial
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Jonathan Elmer, MD, MS
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported